Literature DB >> 25772740

Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure.

Abhishek Sharma1, Carl J Lavie2, Jeffrey S Borer3, Ajay Vallakati4, Sunny Goel5, Francisco Lopez-Jimenez6, Armin Arbab-Zadeh7, Debabrata Mukherjee8, Jason M Lazar9.   

Abstract

Clinical studies have indicated the existence of an "obesity paradox" in patients with chronic heart failure (HF), that is, reduced mortality in patients who have elevated body mass index (BMI) scores compared with normal-weight reference groups. The aim of this study was to investigate the relation of BMI with all-cause and cardiovascular (CV) mortality and hospitalization in patients with chronic HF though a systematic review and meta-analysis of published research. PubMed, the Cumulative Index to Nursing and Allied Health Literature, Cochrane Central, Scopus, web of science and Embase were searched for studies reporting rates of total mortality, cardiac mortality, and risk for hospitalization in patients with HF in various BMI categories (<20 kg/m(2) [low], 20 to 24.9 kg/m(2) [normal reference], 25 to 29.9 kg/m(2) [overweight], 30 to 34.9 [obese], and ≥35 kg/m(2) [severely obese]). Event rates were compared using a forest plot of relative risk (RR) using a random-effects model assuming interstudy heterogeneity. Two study investigators independently reviewed the 124 reports retrieved and identified 6 for final analyses (n = 22,807). After a mean follow-up period of 2.85 years, the risk for adverse events was highest in patients with low BMIs: total mortality RR 1.27 (95% confidence interval [CI] 1.17 to 1.37), CV mortality RR 1.20 (95% CI 1.01 to 1.43), and hospitalization RR 1.19 (95% CI 1.09 to 1.30). Risk for CV mortality and hospitalization was lowest in overweight patients (RR 0.79, 95% CI 0.70 to 0.90, and RR 0.92, 95% CI 0.86 to 0.97, respectively). Increasing degree of obesity failed to achieve a statistically significant effect on CV mortality (RR 0.82, 95% CI 0.64 to 1.05, and RR 0.71, 95% CI 0.50 to 1.01, for obese and severely obese, respectively) and on hospitalization (RR 0.99, 95% CI 0.92 to 1.07, and RR 1.28, 95% CI 0.88 to 1.87, for obese and severely obese, respectively). In conclusion, risk for total mortality and CV mortality and hospitalization was highest in patients with chronic HF who were underweight as defined by low BMI, whereas risk for CV mortality and hospitalization was lowest in overweight subjects.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25772740     DOI: 10.1016/j.amjcard.2015.02.024

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  93 in total

1.  Relation between adiposity and vascular events, malignancy and mortality in patients with stable cerebrovascular disease.

Authors:  N E M Jaspers; J A N Dorresteijn; Y van der Graaf; J Westerink; L J Kappelle; H M Nathoe; A Algra; F L J Visseren
Journal:  Int J Obes (Lond)       Date:  2017-08-04       Impact factor: 5.095

2.  Recent Publications by Ochsner Authors.

Authors: 
Journal:  Ochsner J       Date:  2015

3.  Hematopoietic-to-mesenchymal transition of adipose tissue macrophages is regulated by integrin β1 and fabricated fibrin matrices.

Authors:  Kathleen M Gavin; Susan M Majka; Wendy M Kohrt; Heidi L Miller; Timothy M Sullivan; Dwight J Klemm
Journal:  Adipocyte       Date:  2017-04-03       Impact factor: 4.534

Review 4.  Dietary Self-management in Heart Failure: High Tech or High Touch?

Authors:  Eloisa Colin-Ramirez; JoAnne Arcand; Justin A Ezekowitz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-03

Review 5.  Cardiometabolic Disease Leading to Heart Failure: Better Fat and Fit Than Lean and Lazy.

Authors:  Ambarish Pandey; Jarett D Berry; Carl J Lavie
Journal:  Curr Heart Fail Rep       Date:  2015-10

6.  No Obesity Paradox in Pediatric Patients With Dilated Cardiomyopathy.

Authors:  Chesney D Castleberry; John L Jefferies; Ling Shi; James D Wilkinson; Jeffrey A Towbin; Ryan W Harrison; Joseph W Rossano; Elfriede Pahl; Teresa M Lee; Linda J Addonizio; Melanie D Everitt; Justin Godown; Joseph Mahgerefteh; Paolo Rusconi; Charles E Canter; Steven D Colan; Paul F Kantor; Hiedy Razoky; Steven E Lipshultz; Tracie L Miller
Journal:  JACC Heart Fail       Date:  2018-02-07       Impact factor: 12.035

Review 7.  Obesity and cardiovascular disease in women.

Authors:  Camila Manrique-Acevedo; Bhavana Chinnakotla; Jaume Padilla; Luis A Martinez-Lemus; David Gozal
Journal:  Int J Obes (Lond)       Date:  2020-02-17       Impact factor: 5.095

8.  Weight change in heart failure inpatients not associated with 30-day readmission.

Authors:  Michael G Nanna; Alexander E Sullivan; Vlada Bazylevska; Risa L Wong; Terrence E Murphy; Lavanya Bellumkonda; Robert L McNamara
Journal:  Future Cardiol       Date:  2020-04-14

9.  Long-Term Weight Gain Associated With High Omentin Levels at Hospital Discharge Improves Prognosis of Patients Following Acute Heart Failure.

Authors:  Rosa M Agra-Bermejo; Rocio Gonzalez-Ferreiro; J Nicolos Lopez-Canoa; Alfonso Varela-Roman; Ines Gomez-Otero; Sonia Eiras; José R González-Juanatey
Journal:  J Cardiovasc Transl Res       Date:  2018-10-23       Impact factor: 4.132

10.  Presence of obesity is associated with lower mortality in elderly patients with implantable cardioverter defibrillator.

Authors:  A Jahangir; M Mirza; M Shahreyar; T Mengesha; R Shearer; S Sultan; A Jahangir; I Choudhuri; V Nangia; A Dhala; A Bhatia; I Niazi; J Sra; A J Tajik
Journal:  Int J Obes (Lond)       Date:  2017-08-30       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.